Skip to content
Screener

Ensysce Biosciences, Inc. ENSC Q2 2026 earnings

Reported August 13, 2026 · Before market open

Revenue$1.2MMiss by $35.7K
EPS-$0.20In line
Revenue estimate$1.2M
EPS estimate-$0.20

Next report

Nov 13, 2026 (in 2 months)
Revenue estimate$1.2M
EPS estimate-$0.19

FAQ

When did Ensysce Biosciences, Inc. report Q2 2026 earnings?
Ensysce Biosciences, Inc. (ENSC) reported Q2 2026 earnings on August 13, 2026 before market open.
What were Ensysce Biosciences, Inc.'s Q2 2026 revenue and EPS?
Ensysce Biosciences, Inc. reported revenue of $1.2M and eps of $-0.20 for Q2 2026.
Did Ensysce Biosciences, Inc. beat estimates in Q2 2026?
Revenue missed the consensus estimate of $1.2M by $35.7K. EPS beat the consensus estimate of $-0.20 by $0.00.
How did Ensysce Biosciences, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 15.1% from $1.4M a year earlier and eps grew 74.7% from $-0.79.
Where can I find Ensysce Biosciences, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-037794) and the 10-Q periodic report (0001493152-26-037817) directly on SEC EDGAR. The filing index links above go to sec.gov.